Clinical Trial Update: A Study Comparing CRx-102 Plus Disease-modifying Anti-rheumatic Drug (DMARD) Therapy to Placebo Plus DMARD Therapy in RA [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating CRx-102 added to DMARD therapy versus placebo added to DMARD therapy in rheumatoid arthritis; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• CRx-102

Snippet

Sponsor: Zalicus | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED | Results posted: 2014-05-20